NCT07124403View on ClinicalTrials.gov

DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure

Not yet recruitingOBSERVATIONAL
Enrollment

742

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

September 30, 2028

Conditions
Renal ImpairmentDigestive CancersBreast Cancer
Interventions
DIAGNOSTIC_TEST

blood sampling

DPD Activity wil be assessed from blood samples

DIAGNOSTIC_TEST

Blood sampling

Measurement of uracilemia and assessment of renal function

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER